Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes

This analysis compared azacitidine (AZA) to conventional care regimens (CCR) and their associated overall survival (OS) and tolerability in the subset of 87 elderly (≥75 years) patients with higher-risk MDS (FAB: RAEB, RAEB-t, CMML and IPSS: Int-2 or High) from the AZA-001 trial. Patients were rando...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Seymour, John F., Fenaux, Pierre, Silverman, Lewis R., Mufti, Ghulam J., Hellström-Lindberg, Eva, Santini, Valeria, List, Alan F., Gore, Steven D., Backstrom, Jay, McKenzie, David, Beach, C.L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4000027/
https://ncbi.nlm.nih.gov/pubmed/20451404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2010.04.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados